NeuroOne Medical Technolo...

NASDAQ: NMTC · Real-Time Price · USD
0.83
0.00 (0.00%)
At close: Aug 15, 2025, 2:20 PM

NeuroOne Medical Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Cash & Equivalents
1.32M 1.13M 1.46M 1.62M 2.43M 2.68M 5.32M 3.08M 3.6M 4.67M 8.16M 10.18M 12.87M 16.18M 6.9M 8.99M 11.27M 7.13M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a 995.43K 2.98M 2.98M n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables
318.78K 2.37M 176.64K 410.55K 555.64K 543.4K n/a n/a 213.95K 95.32K 33.24K n/a 36.58K 24.63K 48.34K 40.1K n/a 71.47K
Inventory
1.83M 1.93M 2.64M 1.79M 1.31M 1.61M 1.73M 1.52M 1.17M 903.55K 704.54K 454.29K 221.9K 229.12K 98.29K 52.18K n/a 13.82K
Other Current Assets
72.38K 82.96K 142.63K n/a n/a 21.32K n/a 67.16K n/a 103.79K n/a -1 n/a n/a 92.93K n/a n/a n/a
Total Current Assets
3.75M 5.71M 4.63M 4.09M 4.71M 5.09M 7.31M 4.88M 6.36M 8.97M 12.18M 10.93M 13.44M 16.58M 7.29M 9.27M 11.36M 7.34M
Property-Plant & Equipment
646.5K 720.98K 671.75K 754.32K 606.74K 645.37K 694.81K 784.2K 747.82K 586.92K 534.95K 524.19K 523K 479.3K 512.28K 397.51K 416.5K 421.81K
Goodwill & Intangibles
56.1K 61.68K 67.26K 72.84K 78.42K 84K 89.58K 95.16K 100.73K 106.31K 111.89K 117.47K 123.05K 128.63K 134.21K 139.79K 145.37K 150.94K
Total Long-Term Assets
702.61K 782.66K 739.01K 827.16K 685.16K 729.37K 784.39K 879.35K 848.55K 693.23K 646.85K 641.66K 646.05K 607.93K 646.48K 537.29K 561.86K 572.75K
Total Assets
4.46M 6.49M 5.37M 4.91M 5.39M 5.82M 8.1M 5.76M 7.21M 9.66M 12.82M 11.57M 14.09M 17.18M 7.94M 9.81M 11.92M 7.91M
Account Payables
910.75K 744.52K 1.03M 759.26K 780.84K 760K 685.1K 958.81K 953.45K 861.64K 927.66K 325.03K 446.02K 703.72K 528.83K 296.41K 345.79K 519.52K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.46M 2.25K 2.25K 2.25K 8.62K 13.6K 31.05K 51.16K
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
60.58K 826.39K 59.95K n/a n/a n/a n/a n/a n/a n/a n/a 105.23K 68.6K n/a n/a 156.15K 208.51K 5.27M
Total Current Liabilities
1.76M 1.57M 2.21M 1.69M 1.54M 1.38M 1.79M 1.75M 1.55M 1.33M 3.1M 814.52K 810.23K 1.06M 1.18M 746.85K 750.37K 6.18M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
1.36M 1.75M 2.14M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 83.33K 83.33K
Total Long-Term Liabilities
1.57M 1.99M 2.33M 209.91K n/a 20.98K 55.28K 88.92K 121.9K 153.72K 119.56K 137.96K 156.04K 173.31K 202.9K 206.97K 306.69K 322.31K
Total Liabilities
3.33M 3.56M 4.55M 1.9M 1.54M 1.4M 1.85M 1.84M 1.67M 1.49M 3.22M 952.48K 966.27K 1.24M 1.38M 953.82K 1.06M 6.5M
Total Debt
311.41K 341.51K 260.16K 290.09K 121.9K 153.72K 184.4K 214.48K 243.98K 272.4K 202.9K 232.01K 260.67K 288.39K 315.67K 269.41K 284.24K 298.33K
Common Stock
31.39K 30.84K 30.82K 27.85K 26.32K 24.83K 23.93K 17.86K 16.89K 16.24K 16.22K 16.2K 40.02K 40.01K 12.01K 35.8K 35.73K 23.09K
Retained Earnings
-75.49M -73.22M -75M -71.65M -68.89M -66.03M -62.69M -59.55M -56.08M -52.56M -50.83M -49.45M -46.69M -43.63M -40.83M -38.18M -35.23M -32.84M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
1.13M 2.94M 822.01K 3.01M 3.85M 4.42M 6.25M 3.92M 5.53M 8.17M 9.6M 10.62M 13.12M 15.95M 6.55M 8.85M 10.86M 1.41M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a 995.43K 2.98M 2.98M n/a n/a n/a n/a n/a n/a n/a